Search Results | Diabetes Care | American Diabetes Association

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Guntram Schernthaner, MD, Jorge L. Gross, MD, Julio Rosenstock, MD, Michael Guarisco, MD, Min Fu, MS, Jacqueline Yee, MS, Masato Kawaguchi, MD, William Canovatchel, MD, Gary Meininger, MD

Diabetes Care 2013;36(9):2508–2515

DOI: https://doi.org/10.2337/dc12-2491

Published: 13 August 2013

View article

Includes: Supplementary data

Journal Articles

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

Guntram Schernthaner, MD, Craig J. Currie, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2013;36(Supplement_2):S155–S161

DOI: https://doi.org/10.2337/dcS13-2031

Published: 17 July 2013

View article

Journal Articles

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time

Thomas Hörtenhuber, MD, Birgit Rami-Mehar, MD, Miriam Satler, MS, Katrin Nagl, MD, Clemens Höbaus, MD, Florian Höllerl, MD, Renate Koppensteiner, MD, Guntram Schernthaner, MD, Edith Schober, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2013;36(6):1647–1653

DOI: https://doi.org/10.2337/dc12-1206

Published: 15 May 2013

View article

Includes: Supplementary data

Journal Articles

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

Diabetes Care 2013;36(4):908–913

DOI: https://doi.org/10.2337/dc12-0931

Published: 14 March 2013

View article

Includes: Supplementary data

Journal Articles

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Pascale Fouqueray, MD, Valdis Pirags, MD, Silvio E. Inzucchi, MD, Clifford J. Bailey, PHD, Guntram Schernthaner, MD, Michaela Diamant, MD, Harold E. Lebovitz, MD

Diabetes Care 2013;36(3):565–568

DOI: https://doi.org/10.2337/dc12-0453

Published: 13 February 2013

View article

Journal Articles

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Guntram Schernthaner, MD, Johanna M. Brix, MD, Hans-Peter Kopp, MD, Gerit Holger Schernthaner, MD

Diabetes Care 2011;34(Supplement_2):S355–S360

DOI: https://doi.org/10.2337/dc11-s253

Published: 22 April 2011

View article

Journal Articles

Hypoglycemia and Cardiovascular Risks

Brian M. Frier, MD, Guntram Schernthaner, MD, Simon R. Heller, MD

Diabetes Care 2011;34(Supplement_2):S132–S137

DOI: https://doi.org/10.2337/dc11-s220

Published: 22 April 2011

View article

Journal Articles

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

David Peter Lorant, MD, Milan Grujicic, MD, Clemens Hoebaus, MD, Johanna-Maria Brix, MD, Florian Hoellerl, MD, Guntram Schernthaner, MD, Renate Koppensteiner, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2011;34(1):156–161

DOI: https://doi.org/10.2337/dc10-0788

Published: 07 October 2010

View article

Journal Articles

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Guntram Schernthaner, MD, John M. Morton, MD

Diabetes Care 2008;31(Supplement_2):S297–S302

DOI: https://doi.org/10.2337/dc08-s270

Published: 01 February 2008

View article

Journal Articles

Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes

Katarzyna Krzyzanowska, MD, Friedrich Mittermayer, MD, Michael Wolzt, MD, Guntram Schernthaner, MD

Diabetes Care 2007;30(7):1834–1839

DOI: https://doi.org/10.2337/dc07-0019

Published: 01 July 2007

View article

Journal Articles

Response to Iafusco et al.

Guntram Schernthaner, MD, Wolfgang Wein, MD

Diabetes Care 1998;21(10):1778

DOI: https://doi.org/10.2337/diacare.21.10.1778a

Published: 01 October 1998

View article

Journal Articles

Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients

Guntram Schernthaner, MD, Wolfgang Wein, MD, Klaudia Sandholzer, MD, Susanna Equiluz-Bruck, MD, Peter C Bates, PHD, Martin A Birkett, BSC

Diabetes Care 1998;21(4):570–573

DOI: https://doi.org/10.2337/diacare.21.4.570

Published: 01 April 1998

View article

Journal Articles

Slow Gastric Emptying in Type I Diabetes: Relation to Autonomic and Peripheral Neuropathy, Blood Glucose, and Glycemic Control

René Merio, MD, Andreas Festa, MD, Helmar Bergmann, PHD, Thomas Eder, MD, Nicole Eibl, MD, Giselheld Stacher-Janotta, Ute Weber, Christine Budka, Andrea Heckenberg, MA, Peter Bauer, PHD, Mario Francesconi, MD, Guntram Schernthaner, MD, Georg Stacher, MD

Diabetes Care 1997;20(3):419–423

DOI: https://doi.org/10.2337/diacare.20.3.419

Published: 01 March 1997

View article

Journal Articles

The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Hans-Peter Kopp, MD, Walter Krugluger, MD, Andreas Festa, MD, Guntram Schernthaner, MD

Diabetes Care 1995;18(6):883–884

DOI: https://doi.org/10.2337/diacare.18.6.883

Published: 01 June 1995

View article

Journal Articles

Hypomagnesemia in Type II Diabetes: Effect of a 3-Month Replacement Therapy

Nicole L Eibl, MD, Hans-Peter Kopp, MD, Helga R Nowak, MD, Christoph J Schnack, MD, Pierre G Hopmeier, MD, Guntram Schernthaner, MD

Diabetes Care 1995;18(2):188–192

DOI: https://doi.org/10.2337/diacare.18.2.188

Published: 01 February 1995

View article

Journal Articles

Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients

Christoph Schnack, MD, Rudolf JF Prager, MD, Johanna Winkler, MD, Renate M Klauser, MD, Barbara G Schneider, PhD, Guntram Schernthaner, MD

Diabetes Care 1989;12(8):537–543

DOI: https://doi.org/10.2337/diacare.12.8.537

Published: 01 September 1989

View article

Journal Articles

Dawn Phenomenon and Somogyi Effect in IDDM

Judith M Stephenson, MB, Guntram Schernthaner, MD

Diabetes Care 1989;12(4):245–251

DOI: https://doi.org/10.2337/diacare.12.4.245

Published: 01 April 1989

View article

NARROW

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Hypoglycemia and Cardiovascular Risks

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes

Response to Iafusco et al.

Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients

Slow Gastric Emptying in Type I Diabetes: Relation to Autonomic and Peripheral Neuropathy, Blood Glucose, and Glycemic Control

The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Hypomagnesemia in Type II Diabetes: Effect of a 3-Month Replacement Therapy

Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients

Dawn Phenomenon and Somogyi Effect in IDDM

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only